Susan S. Jick, DSc
Adjunct Professor
Boston University School of Public Health
Dept of Epidemiology

MPH, Boston University
DSc, Boston University



Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.


Iodinated contrast agents and risk of hypothyroidism in young children in the United States
04/29/2016 - 10/31/2017 (PI)
Bayer AG


Maternal depression and antidepressant use during pregnancy and risk of childhood autism spectrum disorders in offspring
09/01/2015 - 08/31/2017 (PI)
NIH/National Institute of Child Health & Human Development
5R01HD084680-02

A Postmarketing Surveillance Study of Otezla
11/01/2015 - 07/21/2017 (PI)
Celgene Corporation


Study of patients with rare disease
05/27/2016 - 05/26/2017 (PI)
EpiSource, LLC Genzyme Corporation


Longitudinal Study of Morbidity and Mortality in Primary Vasculitis
03/01/2015 - 02/28/2017 (PI)
Vasculitis Foundation


Prevalence of hypercalcemia of malignancy (HCM) among cancer patients (C14-018)
02/14/2014 - 12/31/2016 (PI)
Amgen, Inc.


Persistent Side-Effects of 5-Alpha-Reductase Inhibitor Treatment
09/01/2014 - 07/31/2016 (PI)
New England Research Institutes NIH NIDDK
R21DK100820

Incidence, prevalence and treatment patterns of pediatric pulmonary hypertension in the US
09/21/2015 - 03/31/2016 (PI)
Bayer AG


A study to estimate the prevalence of diabetic nephropathy in a pediatric United States population
12/19/2014 - 06/30/2015 (PI)
Bayer AG


Epidemiology of Giant Cell Tumor of the Bone in the UK - Phase II (C13-135)
12/01/2013 - 04/30/2015 (PI)
Amgen, Inc.


Showing 10 of 14 results. Show All Results


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Imfeld P, Bodmer M, Jick SS, Meier CR. Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis. Drug Saf. 2018 Aug 27. PMID: 30146658.
     
  2. Frey N, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study. Drug Saf. 2018 Aug 16. PMID: 30112729.
     
  3. Mueller AM, Meier CR, Jick SS, Schneider C. The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus: A Case-Control Study. Pancreas. 2018 Aug; 47(7):807-815. PMID: 29975346.
     
  4. Gruntz K, Bloechliger M, Becker C, Jick S, Fuhr P, Meier CR, Rüegg S. Reply to "Intriguing association of Parkinson disease and epileptic seizures". Ann Neurol. 2018 Jul; 84(1):162-163. PMID: 29740876.
     
  5. Burkard T, Hügle T, Layton JB, Glynn RJ, Bloechliger M, Frey N, Jick SS, Meier CR, Spoendlin J. The risk of incident osteoarthritis of the hand in statin initiators:A sequential cohort study. Arthritis Care Res (Hoboken). 2018 Jun 08. PMID: 29885074; DOI: 10.1002/acr.23616;.
     
  6. Wilson JC, Sarsour K, Gale S, Pethö-Schramm A, Jick SS, Meier CR. Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2018 Jun 01. PMID: 29856128.
     
  7. Li L, Neogi T, Jick S. Mortality in Patients With Giant Cell Arteritis: A Cohort Study in UK Primary Care. Arthritis Care Res (Hoboken). 2018 Aug; 70(8):1251-1256.View Related Profiles. PMID: 29409137.
     
  8. Gale S, Wilson JC, Chia J, Trinh H, Tuckwell K, Collinson N, Dimonaco S, Jick S, Meier C, Mohan SV, Sarsour K. Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UK. Rheumatol Ther. 2018 May 11. PMID: 29752705.
     
  9. Frey N, Bodmer M, Bircher A, Rüegg S, Jick SS, Meier CR, Spoendlin J. Response: The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs: Comment on data sparsity. Epilepsia. 2018 May; 59(5):1084-1085. PMID: 29723402.
     
  10. Bloechliger M, Reinau D, Spoendlin J, Chang SC, Kuhlbusch K, Heaney LG, Jick SS, Meier CR. Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis. Respir Res. 2018 04 27; 19(1):75. PMID: 29699563.
     
Showing 10 of 274 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 274 publications over 33 distinct years, with a maximum of 27 publications in 2016

YearPublications
19841
19862
19871
19881
19896
19906
19911
19926
19936
19953
19962
19974
19984
19995
20007
20012
20022
20035
20047
20054
20068
20079
200812
200914
201011
20118
201211
201325
201424
201521
201627
201717
201812
Contact for Mentoring:


11 Muzzey St
Lexington MA 02421
Google Map


Jick's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department